Literature DB >> 17101789

HP1 proteins are essential for a dynamic nuclear response that rescues the function of perturbed heterochromatin in primary human cells.

Rugang Zhang1, Song-tao Liu, Wei Chen, Michael Bonner, John Pehrson, Timothy J Yen, Peter D Adams.   

Abstract

Cellular information is encoded genetically in the DNA nucleotide sequence and epigenetically by the "histone code," DNA methylation, and higher-order packaging of DNA into chromatin. Cells possess intricate mechanisms to sense and repair damage to DNA and the genetic code. However, nothing is known of the mechanisms, if any, that repair and/or compensate for damage to epigenetically encoded information, predicted to result from perturbation of DNA and histone modifications or other changes in chromatin structure. Here we show that primary human cells respond to a variety of small molecules that perturb DNA and histone modifications by recruiting HP1 proteins to sites of altered pericentromeric heterochromatin. This response is essential to maintain the HP1-binding kinetochore protein hMis12 at kinetochores and to suppress catastrophic mitotic defects. Recruitment of HP1 proteins to pericentromeres depends on histone H3.3 variant deposition, mediated by the HIRA histone chaperone. These data indicate that defects in pericentromeric epigenetic heterochromatin modifications initiate a dynamic HP1-dependent response that rescues pericentromeric heterochromatin function and is essential for viable progression through mitosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17101789      PMCID: PMC1800672          DOI: 10.1128/MCB.01639-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  73 in total

1.  Changes in the levels of three different classes of histone mRNA during murine erythroleukemia cell differentiation.

Authors:  D T Brown; S E Wellman; D B Sittman
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

2.  Modulation of histone H3 variant synthesis during the myoblast-myotube transition of chicken myogenesis.

Authors:  A M Wunsch; J Lough
Journal:  Dev Biol       Date:  1987-01       Impact factor: 3.582

3.  Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies.

Authors:  W Earnshaw; B Bordwell; C Marino; N Rothfield
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

4.  Conservation of deposition-related acetylation sites in newly synthesized histones H3 and H4.

Authors:  R E Sobel; R G Cook; C A Perry; A T Annunziato; C D Allis
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

5.  Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors.

Authors:  Melissa J Peart; Gordon K Smyth; Ryan K van Laar; David D Bowtell; Victoria M Richon; Paul A Marks; Andrew J Holloway; Ricky W Johnstone
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

6.  Changes in nucleosomal core histone variants during chicken development and maturation.

Authors:  M K Urban; A Zweidler
Journal:  Dev Biol       Date:  1983-02       Impact factor: 3.582

7.  Induction of H3.3 replacement histone mRNAs during the precommitment period of murine erythroleukemia cell differentiation.

Authors:  D B Krimer; G Cheng; A I Skoultchi
Journal:  Nucleic Acids Res       Date:  1993-06-25       Impact factor: 16.971

8.  Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A.

Authors:  M Yoshida; T Beppu
Journal:  Exp Cell Res       Date:  1988-07       Impact factor: 3.905

9.  Specific alterations in the pattern of histone-3 synthesis during conversion of human leukemic cells to terminally differentiated cells in culture.

Authors:  P Pantazis; W M Bonner
Journal:  Differentiation       Date:  1984       Impact factor: 3.880

10.  Regulation of nucleosomal core histone variant levels in differentiating murine erythroleukemia cells.

Authors:  G W Grove; A Zweidler
Journal:  Biochemistry       Date:  1984-09-11       Impact factor: 3.162

View more
  38 in total

1.  Identification of cellular proteins that maintain retroviral epigenetic silencing: evidence for an antiviral response.

Authors:  Andrey Poleshko; Ivan Palagin; Rugang Zhang; Pamela Boimel; Carolyn Castagna; Peter D Adams; Anna Marie Skalka; Richard A Katz
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

2.  Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer.

Authors:  Katherine M Aird; Hua Li; Frances Xin; Panagiotis A Konstantinopoulos; Rugang Zhang
Journal:  Cell Cycle       Date:  2013-10-29       Impact factor: 4.534

Review 3.  Histone variants: emerging players in cancer biology.

Authors:  Chiara Vardabasso; Dan Hasson; Kajan Ratnakumar; Chi-Yeh Chung; Luis F Duarte; Emily Bernstein
Journal:  Cell Mol Life Sci       Date:  2013-05-08       Impact factor: 9.261

4.  A damage limitation exercise.

Authors:  Andrejs Ivanov; Peter D Adams
Journal:  Nat Cell Biol       Date:  2011-03       Impact factor: 28.824

5.  BRG1 is required for formation of senescence-associated heterochromatin foci induced by oncogenic RAS or BRCA1 loss.

Authors:  Zhigang Tu; Xinying Zhuang; Yong-Gang Yao; Rugang Zhang
Journal:  Mol Cell Biol       Date:  2013-02-25       Impact factor: 4.272

6.  Detection of senescence-associated heterochromatin foci (SAHF).

Authors:  Katherine M Aird; Rugang Zhang
Journal:  Methods Mol Biol       Date:  2013

7.  Chromatin dynamics during DNA repair revealed by pair correlation analysis of molecular flow in the nucleus.

Authors:  Elizabeth Hinde; Xiangduo Kong; Kyoko Yokomori; Enrico Gratton
Journal:  Biophys J       Date:  2014-07-01       Impact factor: 4.033

Review 8.  Chromatin maintenance and dynamics in senescence: a spotlight on SAHF formation and the epigenome of senescent cells.

Authors:  Armelle Corpet; Manuel Stucki
Journal:  Chromosoma       Date:  2014-05-27       Impact factor: 4.316

9.  Phase II trial of vorinostat in advanced melanoma.

Authors:  N B Haas; I Quirt; S Hotte; E McWhirter; R Polintan; S Litwin; P D Adams; T McBryan; L Wang; L P Martin; M vonMehren; R K Alpaugh; J Zweibel; A Oza
Journal:  Invest New Drugs       Date:  2014-01-25       Impact factor: 3.850

10.  A single mutation results in diploid gamete formation and parthenogenesis in a Drosophila yemanuclein-alpha meiosis I defective mutant.

Authors:  Régis E Meyer; Michèle Delaage; Roland Rosset; Michèle Capri; Ounissa Aït-Ahmed
Journal:  BMC Genet       Date:  2010-11-16       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.